Trial Profile
Retrospective multicenter study of dexamethasone implant (Ozurdex) or Triamcinolone acetate with bevacizumab in refractory cystoid macular oedema due to retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Triamcinolone (Primary) ; Bevacizumab
- Indications Retinal oedema; Retinal vein occlusion
- Focus Adverse reactions; Therapeutic Use
- Acronyms THE OMAR STUDY
- 04 Feb 2016 New trial record